Delivery Order SPE2DB22D3401-SPE2DB25FT2UR

Award Date 3/20/25
Potential Completion Date 3/21/25
Potential Value $9.7K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,068.23 firm-fixed-price delivery order is for the supply of 100 units of 200 mg progesterone capsules. The contract has an ultimate completion date of October 24, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $8,079.72 firm fixed-price delivery order is for the supply of 4567646130 - Progesterone 200 mg Capsule 100s, with a completion date of March 21, 2025. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $28,025.70 Firm Fixed Price Delivery Order contract is for the supply of 4,567,378,704 units of the 200 mg Progesterone capsule product. The award has a completion date of February 26, 2025 and does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a $999,999,999 Indefinite...
This federal contract award, valued at $4,780.54, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is for the delivery of Progesterone 200 mg capsules, a critical pharmaceutical product, to support military healthcare programs and federal medical institutions. The contract is a Firm Fixed Price Delivery Order, without any set-aside designation, indicating open competition....
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $12,286.65 firm fixed price delivery order is for the supply of 4,567,118,682 units of Progesterone 100 mg capsules. The award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical. This IDC serves as the primary vehicle for...
This federal contract award, valued at $9,830.30, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4,567,646,323 units of Progesterone 100 mg capsules, a medication used in various medical treatments. The contract is a Firm Fixed Price Delivery Order with a completion date of March 21, 2025. The contract is not designated as a set-aside and was awarded through...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $28,058.59 Firm Fixed Price delivery order is for the supply of 4567570471 - Progesterone 200 mg Capsule 100s. The contract has an ultimate completion date of March 14, 2025. This award is associated with AmerisourceBergen's Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The Defense Logistics Agency (DLA) awarded this $33,274.46 Firm Fixed Price Delivery Order for 4,567,038,407 units of Progesterone 200 mg Capsule 100s. The contract has an ultimate completion date of January 27, 2025. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical that serves as a primary...
This federal contract award SPE2DB25D3006|SPE2DB25FXHMP, valued at $4,870.45, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4567571500 - Progesterone 200 mg Capsules, 100 count, and has a period of performance through March 14, 2025. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at...
This federal contract award is for the delivery of progesterone 100 mg capsules to the Defense Logistics Agency (DLA), a defense agency. The contract was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, on December 19, 2024. The contract has a ceiling value of $1,023.56 and is a Firm Fixed Price Delivery Order with a completion date of December 20, 2024. The contract was not set aside for any specific business designation....
  • SPE2DB22D3401
    Indefinite Delivery Contract
  • SPE2DB22D3401-SPE2DB25FT2UR
    Delivery Order

This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $9,749.40, is for the delivery of 4,567,645,384 units of Progesterone 200 mg capsules in 100-count packages. The contract has no set-aside designation, indicating open competition.

AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The company also maintains a separate IDC with the Department of Justice Federal Bureau of Investigation, valued at $750,000 through May 2024, which covers similar medical products and prescription drugs.

Generated 6/19/25, 9:49 AM